These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 574057)

  • 21. Genitourinary malignancies.
    Smith MR; Kantoff P
    Cancer Chemother Biol Response Modif; 1999; 18():394-417. PubMed ID: 10800495
    [No Abstract]   [Full Text] [Related]  

  • 22. [The chemotherapy of urologic neoplasms].
    Cavalli F
    Helv Chir Acta; 1978 Jul; 45(3):223-32. PubMed ID: 359509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chemotherapy of solid tumors. The role of cisplatin in today's chemotherapy].
    Kenis Y; Rozencweig M; Sanders C
    Rev Med Brux; 1983 Apr; 4(4):213-7. PubMed ID: 6683864
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cytostatic adjuvant therapy of tumors in the urogenital region].
    Vahlensieck W
    Haematol Blood Transfus; 1978; 22():165-74. PubMed ID: 220154
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of Peptichemio in neoplasms of the urogenital system].
    Aliffi E; De Grande G
    Minerva Urol; 1976 SEP-OCT; 28(5):247-52. PubMed ID: 1004464
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase II trial adriamycin and cis-dichlorodiammineplatinum(II) in squamous cell, ovarian, and testicular carcinomas.
    Bonomi PD; Slayton RE; Wolter J
    Cancer Treat Rep; 1978 Aug; 62(8):1211-3. PubMed ID: 356979
    [No Abstract]   [Full Text] [Related]  

  • 27. [The role of etoposide therapy in urogenital cancer].
    Kawai K; Akaza H
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1929-35. PubMed ID: 8978800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of urogenital neoplasms in males].
    Sonntag RW
    Schweiz Med Wochenschr; 1978 Sep; 108(36):1404-10. PubMed ID: 568306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chemotherapy of urologic metastases].
    Zanoni F; Piva L; Milani A; Salvioni R; Faustini M; Nicolai N; Mangiarotti B; Pizzocaro G
    Arch Ital Urol Nefrol Androl; 1992 Mar; 64(1):37-43. PubMed ID: 1570524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
    Suzuki K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2772-9. PubMed ID: 3753024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of combination chemotherapy with cis-diamminedichloroplatinum (II) (CDDP) on renal function in patients with urogenital malignancies].
    Kawamura J; Hida S; Higashi Y; Yamauchi T; Soeda A; Yoshida O
    Hinyokika Kiyo; 1985 Feb; 31(2):207-21. PubMed ID: 4040315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cytostatic therapy of metastasizing cancers: therapeutic indications and limitations (author's transl)].
    Huber H; Denz H; Kratzer H
    Wien Klin Wochenschr; 1977 Apr; 89(7):209-15. PubMed ID: 324137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin: impact of a new anticancer agent on current therapeutic strategies.
    Rozencweig M; Abele R; von Hoff DD; Muggia FM
    Anticancer Res; 1981; 1(4):199-204. PubMed ID: 7049048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new anti-cancer agent, bestrabucil (KM 2210): I. Concentration in the serum and tissue in urogenital tumors].
    Nasu Y; Saegusa M; Hara M; Ochi J; Akagi T; Obama T; Tsushima T; Yoshimoto J; Ozaki Y; Matsumura Y
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1116-21. PubMed ID: 3566306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cis-diammino-dichloro-platinum therapy of cancers; phase II therapeutic trial].
    Hayat M; Bayssas M; Brulé G; Cappelaere P; Cattan A; Chauvergne J; Clavel B; Gouveia J; Guerrin J; Pommatau E; Muggia F; Mathé G
    Nouv Presse Med; 1979 Mar; 8(15):1231-4. PubMed ID: 375187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prospects for using platinum coordination compounds possessing antitumor activity].
    Sidorik EP; Burlaka AP; Sirdorik OA; Korchevaia LM
    Eksp Onkol; 1984; 6(6):6-12. PubMed ID: 6396067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cis-platinum in the treatment of testicular and other cancers.
    Williams SD; Einhorn LH
    Adv Intern Med; 1982; 27():531-45. PubMed ID: 7041553
    [No Abstract]   [Full Text] [Related]  

  • 38. Cis-dichlorodiammineplatinum(II) in advanced bladder cancer.
    Yagoda A; Watson RC; Gonzalez-Vitale JC; Grabstald H; Whitmore WF
    Cancer Treat Rep; 1976 Jul; 60(7):917-23. PubMed ID: 1009522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The chemotherapy of urologic cancer.
    Carter SK; Wasserman TH
    Cancer; 1975 Aug; 36(2):729-47. PubMed ID: 125624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A comparative study of the effects of granisetron alone and a combination of granisetron plus steroids on CDDP-based combination chemotherapy-induced emesis--outcomes of a multicenter randomized comparative study using the central registration method. Nara Medical University Kytril Study Group].
    Ozono S; Okajima E; Hirao YK; Natsume O; Kaneko Y; Ohara S; Tabata S; Watanabe S; Aoyama H; Sasaki K; Matsuki H; Takashima K; Maruyama Y; Yoshikawa M; Yamada K; Momose H; Hiramatsu T; Hayashi Y; Babaya K; Shiomi T
    Gan To Kagaku Ryoho; 1997 Feb; 24(3):349-56. PubMed ID: 9051139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.